在乳腺癌中通过LncRNA调节西斯普拉丁的反应
Shirin Azizidoost1, Mohadeseh Sheykhi-Sabzehpoush2, Mahrokh Abouali Gale Dari3
1Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Pathology, research and practice
|November 13, 2024
概括
乳腺癌中西斯普拉丁耐药性与长非编码RNAs (lncRNAs) 有关. 这些分子与西斯胺相互作用,促进耐药性,并影响这种侵袭性癌症的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳腺癌的转移率,复发率和死亡率都很高.
- 西斯是一种关键的化疗剂,但其有效性因耐药性和毒性而受到损害.
- 由于复杂的抵抗机制,乳腺癌的治疗结果仍然不令人满意.
研究的目的:
- 调查长非编码RNAs (lncRNAs) 在乳腺癌中介于西斯普拉丁耐药性的作用.
- 为了确定特定的lncRNAs参与了对西斯治疗的耐药性发展.
- 阐明 lncRNAs 影响乳腺癌细胞化疗反应的分子机制.
主要方法:
- 文献综述和对最近关于lncRNAs和西斯普拉丁耐药性的研究的分析.
- 确定关键的lncRNAs与乳腺癌化学疗法耐药性有关.
- 检查lncRNAs,microRNAs和mRNAs在调节基因表达中的相互作用.
主要成果:
- 包括SNHG15,HULC,HCP5,MT1JP,LncMat2B,DLX6-ASL,Linc00665,CARMN和Lnc-EinRP44-3:6在内的几种lncRNA被确定为西斯抗性的关键媒介.
- 这些lncRNA与思丁相互作用,加速乳腺癌细胞的耐药性发展.
- lncRNAs通过向microRNAs和mRNAs来调节参与西斯普拉丁耐药性的基因的表达.
结论:
- lncRNAs在乳腺癌中对西斯普拉丁耐药性的发展中发挥着重要作用.
- 针对特定的 lncRNAs 是克服化疗耐药性的潜在治疗策略.
- 了解 lncRNA 介导机制对于改善乳腺癌治疗结果至关重要.
更多相关视频
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:23Regulation of Expression at Multiple Steps
873
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
873
01:46Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
02:55The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
01:29Translational Regulation
1
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
1